Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (KCT0011376) titled 'Effect of EstroG-100 Supplementation on Climacteric Symptoms and Bone Metabolism Markers in Perimenopausal Womem' on Dec. 26, 2025.
Study Type: Interventional Study
Study Design:
Primary Purpose : Supportive Care, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable
Primary Sponsor: Kyung Hee University Global Campus
Condition:
Diseases of the genitourinary system
Intervention:
Others(Health functional food) : Take EstroG-100, a health functional food, for 12 weeks, orally at 2 tablets per day, 1 tablet in the morning and 1 tablet in the afternoon.
Recruitment Status: Recruit...